The Purpose of this clinical trial will compare V116 to PCV20. PCV20 is an approved vaccine for preventing pneumococcal disease in the United States. The V116 vaccine is being tested to protect against the pneumococcal disease.
LYNN HEALTH SCIENCE INSTITUTE IS LOOKING FOR PARTICIPANTS
PAID CLINICAL TRIAL
Trial Last 6 months
2 clinical site visits
3 phone calls
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
18 yrs. or older Male or Female
Overall a healthy adult
Pneumococcal disease is an infection caused by a type of bacteria called Streptococcus pneumoniae. It can cause pneumonia, bloodstream infections, or meningitis.
If you 18 years of age or older and haven’t received a pneumococcal vaccine since childhood. This vaccine helps the body fight infections due to pneumococcal disease and may prevent serious illness.
LEARN MORE ABOUT PARTICIPATING IN A CLINICAL TRIAL
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.